Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109678798B details a silver-catalyzed route for isoquinoline compounds. Offers high yield and scalable manufacturing for pharmaceutical intermediates supply chains.
Novel aqueous-phase synthesis reduces solvent waste and cost. Reliable supply of high-purity Solifenacin intermediate for global pharmaceutical manufacturing.
Patent CN108383786A details asymmetric hydrogenation for dextromethorphan intermediates. Achieves high yield and purity with reduced costs for reliable pharmaceutical supply chains.
Patent CN109293569B reveals solvent-free transamination using DMF. Achieve high-purity pharmaceutical intermediates with significant cost reduction and simplified supply chains.
Novel one-pot synthesis of isoquinoline triazoloindoles via peroxyacetone oxidation. Offers cost reduction in API manufacturing and scalable routes for complex heterocycles.
Novel benzyl isoquinoline compounds with rapid metabolic clearance for safer surgical anesthesia. Cost-effective synthesis routes for pharmaceutical intermediates.
Patent CN100534986C reveals a one-pot method using BTC and DMF, offering mild conditions and high purity for reliable pharmaceutical intermediates supply chains.
Patent CN107163022B discloses novel isoquinoline compounds for Alzheimer's diagnosis. We offer scalable synthesis and reliable supply chain solutions.
Patent CN110028448A reveals a copper-catalyzed synthesis route offering cost reduction and mild conditions for high-purity pharmaceutical intermediates manufacturing.
Patent CN115028626B reveals high-efficiency TADF materials for OLEDs. Discover cost-effective synthesis and supply chain advantages for electronic chemical manufacturing.
Patent CN105130894B reveals manganese-catalyzed isoquinoline synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN1190425C reveals novel sulfation methods for berberine metabolites, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104557911A details a chemo-enzymatic route for (R)-praziquantel. This method ensures high optical purity and significant cost reduction in anthelmintic drug manufacturing.
Patent CN102417523A reveals novel nitrogen heterocyclic ligands enabling high-selectivity asymmetric hydrogenation of hindered ketones for cost-effective pharmaceutical manufacturing.
Novel synthesis of tetrahydroisoquinoline derivative via cyanation and hydrolysis. Offers cost-effective route for API intermediates with high purity.
Patent CN104974052B details a high-yield synthesis route for tetrahydroisoquinoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105198811A reveals a metal-free radical cyclization route for 1,3-isoquinoline dione derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN106397449A reveals metal-free synthesis for high-purity pharmaceutical intermediates offering supply chain stability and cost reduction in manufacturing processes.
Patent CN106397449A details metal-free synthesis for furoisoquinoline derivatives ensuring high purity and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN117143017A details Rh-catalyzed aryl migration for isoquinoline synthesis. This breakthrough offers cost reduction in display & optoelectronic materials manufacturing and supply chain reliability.